Cervicovaginal microbiome and natural history of HPV in a longitudinal study/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks, Victoria

Subjects

Location of subjects
Costa Rica
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Uterine cervix Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Human papilloma virus infection HPV,Human Papilloma Virus Infection,Human papilloma Virus infection,human papilloma virus infection,Human papillomavirus caused disease or disorder,Human papillomavirus disease or disorder,Human Papillomavirus Infection,Human Papillomavirus infection,Human papillomavirus infectious disease,Human papilloma virus infection
Group 0 name Corresponds to the control (unexposed) group for case-control studies
HPV (clearance)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Visit 1 HPV (progression)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
HPV progression to CIN2+ lesion diagnosis
Group 0 sample size Number of subjects in the control (unexposed) group
70
Group 1 sample size Number of subjects in the case (exposed) group
33

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: Cynthia Anderson

Revision editor(s): WikiWorks, Merit

Source: Figure 4

Description: Bacteria associated with progression to CIN2+ identified using LEfSe

Abundance in Group 1: increased abundance in Visit 1 HPV (progression)

NCBI Quality ControlLinks
Aerococcus christensenii
Anaerococcus prevotii
Bifidobacterium bifidum
Bifidobacterium longum subsp. longum
Blautia hansenii
Campylobacter canadensis
Campylobacter ureolyticus
Corynebacterium atypicum
Gardnerella vaginalis
Hallella bergensis
Methylobacillus flagellatus
Methylobacillus glycogenes
Neisseria gonorrhoeae
Peptoniphilus harei
Peptoniphilus indolicus
Porphyromonas bennonis
Prevotella melaninogenica
Prevotella veroralis
Schaalia meyeri
Schaalia odontolytica
Sphingomonas leidyi
Treponema pallidum
Veillonella montpellierensis

Revision editor(s): WikiWorks, Merit

Signature 2

Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: Cynthia Anderson

Revision editor(s): WikiWorks

Source: Figure 4

Description: Bacteria associated with progression to CIN2+ identified using LEfSe

Abundance in Group 1: decreased abundance in Visit 1 HPV (progression)

NCBI Quality ControlLinks
Segatella paludivivens
Lactobacillus iners

Revision editor(s): WikiWorks